Citation Impact
9 standout
Citing Papers
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
Works of Huijing Wu being referenced
Anti-PD-1 Antibody (Sintilimab) Plus Histone Deacetylase Inhibitor (Chidamide) for the Treatment of Refractory or Relapsed Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (r/r-ENKTL): Preliminary Results from a Prospective, Multicenter, Single-Arm, Phase Ib/II Trial (SCENT)
2020
Author Peers
| Author | Oncology | Molecular Biology | PFM | Periodontics | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Huijing Wu | 51 | 61 | 40 | 81 | 25 | 247 | |
| Yanju Ji | 22 | 31 | 513 | ||||
| Jenny Folkesson | 14 | 30 | 7 | 1 | 15 | 505 | |
| Manali Nekkanti | 2 | 5 | 313 | ||||
| Srinivasan Sankaraguruswamy | 29 | 1.3k | |||||
| Rodolfo Paredes | 21 | 150 | 357 | 67 | 51 | 957 |
All Works
Loading papers...